JIM
MNTA

Jupiter Investment Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Jupiter Investment Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-31,262
Closed -$288K – 549
2016
Q1 		$288K Buy
+31,262
New +$336K 0.01% 393

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Jupiter Investment Management's MNTA Position: Q2 2016 in Review

Jupiter Investment Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q2 2016, closing a stake of 31,262 shares — an estimated $288K sold.

Jupiter Investment Management first reported a position in MNTA in Q1 2016 and held it in 1 quarter. The position peaked at $288K in Q1 2016. 146 funds tracked by Wall St. Rank hold MNTA as of Q2 2016.

  • Jupiter Investment Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
  • Jupiter Investment Management sold 31,262 Momenta Pharmaceuticals, Inc. shares in Q2 2016, an estimated $288K.
  • Jupiter Investment Management first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2016 and held it in 1 quarter.
  • Jupiter Investment Management's Momenta Pharmaceuticals, Inc. position peaked at $288K in Q1 2016.
  • 146 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q2 2016.

Based on Jupiter Investment Management's 13F filing for Q2 2016, filed 22 Jul 2016.